Infection of cells with enveloped viruses is accomplished through membrane fusion. The binding and fusion processes are mediated by the spike proteins in the envelope of the virus particle and usually involve a series of conformational changes in these proteins. We have studied the low-pH-mediated fusion process of the alphavirus Semliki Forest virus (SFV). The spike protein of SFV is composed of three copies of the protein heterodimer E2El. This structure is resistant to solubilization in mild detergents such as Nonidet P-40 (NP40).
Infection of cells with enveloped viruses is accomplished through membrane fusion. The binding and fusion processes are mediated by the spike proteins in the envelope of the virus particle and usually involve a series of conformational changes in these proteins. We have studied the low-pH-mediated fusion process of the alphavirus Semliki Forest virus (SFV). The spike protein of SFV is composed of three copies of the protein heterodimer E2El. This structure is resistant to solubilization in mild detergents such as Nonidet P-40 (NP40).
We have recently shown that the spike structure is reorganized during virus entry into acidic endosomes (J. M.
Wahlberg and H. Garoff, J. Cell Biol. 116:339-348, 1992). The original NP40-resistant heterodimer is dissociated, and the El subunits form new NP40-resistant protein oligomers. Here, we show that the new oligomer is represented by an El trimer. From studies that use an in vitro assay for fusion of SFV with liposomes, we show that the El trimer is efficiently expressed during virus-mediated membrane fusion. Time course studies show that both El trimer formation and fusion are fast processes, occumng in seconds. It was also possible to inhibit virus binding and fusion with a monoclonal antibody directed toward the timeric El. These results give support for a model in which the El trimeric structure is involved in the SFV-mediated fusion reaction.
Fusion proteins of membrane viruses constitute remarkably flexible protein structures which express many different functions during the virus life cycle. The fusion proteins are transmembrane polypeptides which generally form homooligomers in the endoplasmic reticula of infected cells before being transported to the site of virus budding, usually the cell surface of the host cell (for reviews, see references 16, 26, 38, and 48) . During virus assembly, fusion proteins have the property of being incorporated into the envelope of the virus particle. At this stage, the membrane fusion potential of the protein is kept silent so that it does not interfere with virus particle maturation. Activation of the fusion potential occurs in a stepwise fashion, often starting with a limited proteolytic cleavage of the subunits in the oligomeric fusion protein, well before maturation and release of the virus particle. In the case of human immunodeficiency virus, it has been shown that binding of virus to cell surface CD4 receptors triggers a second step in the gpl20-gp41 spike activation process (1, 28) .
For membrane viruses which are taken up by receptormediated endocytosis before penetration into the cytoplasm, the low pH of the endosomes represents the final fusion activation step. One of the best known representatives of spike proteins that use this activation pathway is the influenza virus hemagglutinin (HA). This homotrimeric spike has been shown to be converted by the low pH in the endosomes into an intermediate fusion-active state and then further into a fusion-inactive state (14, 36, 37, 40, 41) .
We are interested in the fusion mechanism of alphaviruses. Alphaviruses infect rodents and birds in nature with mosquitoes as vectors and consequently have an exceptionally wide host range (19) . These viruses also show many interesting differences with regard to their assembly and entry features compared with many other enveloped viruses. The * Corresponding author.
spike of alphaviruses consists of three copies of a heterodimeric protomer, E2El, synthesized as a p62El precursor (11, 44, 45, 49, 50) . Before virus particles are released from the cell, the p62 subunit is cleaved to E2 and E3 (8) .
Studies with the alphaviruses Semliki Forest virus (SFV) and Sindbis virus suggest that the p62 protein carries a binding site for the internal nucleocapsid and thereby drives virus budding, whereas the El subunit represents the entry protein which carries fusion activity (13, 15, 27, 29) . The initial step in the activation pathway for SFV entry is the cleavage of p62 (24, 25, 34) . This is different from most other viruses, in which the primary activation step of the entry functions occurs through cleavage of the fusion protein itself. The p62 cleavage facilitates a series of defined changes in the structure of the El subunit, which are induced by low pH during uptake along the receptor-mediated endocytic pathway. They include the dissociation of the original E2El protomeric unit and the formation of new oligomers containing El. These new El oligomers appear to have a role in the virus penetration and fusion process, since this can be inhibited by a monoclonal antibody (anti-El") which reacts specifically with this form of El (46) . SFV fuses readily in vitro with liposomal target membranes (21, 47) . In this system, the pH, temperature, and lipid requirements for SFV membrane fusion have been determined previously (47) . One interesting finding was a strict requirement for the presence of cholesterol in the target membrane (21, 47) . Recently, it has been established that the infectious fusion process of the virus with cells also requires the presence of cholesterol in the target membranes (32 (45) . Mutant virus (mL virus) stocks were prepared either in BHK cells which had been transfected with pSP6-SFV4/mL, as described earlier (23, 34) , or in BHK cells infected with mL virus. Since the mL virus is noninfectious because of its uncleaved p62 subunit, the mL virus was activated by in vitro cleavage of p62 with 15 p,g of trypsin per ml on ice before it was used for infection (34 . Nonadsorbed virus particles were removed, and the cells were incubated for 5 h in minimal essential medium supplemented with 0.2% bovine serum albumin (BSA), 10 mM HEPES, 2 mM glutamine, 100 U of penicillin, 100 ,ug of streptomycin (GIBCO), and 10 ,g of soybean trypsin inhibitor per ml. Labeling and purification were as described for the wt, except that 10 ,ug of the soybean trypsin inhibitor per ml was included in all media and buffers. Virus preparations were plaque titrated with 1.8% low-melting-point agarose in BHK medium, and plaques were visualized by being stained with neutral red. The formation of plaques by the mL virus required the inclusion of trypsin in the agarose overlay (22) . The titers and specific-radioactivity values of the virus preparations used were 2 x 1011 PFU per ml and 235,000 cpm/,ul for the wt and S x 1010 PFU per ml and 250,000 cpm/ljl for the mL virus.
Preparation of liposomes. Large unilamellar vesicles (LUV) were prepared either by detergent dialysis essentially as described previously (43) or by freeze-thaw extrusion (17, 33) . LUV behaved identically in the assays, irrespective of the preparation method. Briefly, for detergent dialysis L-aphosphatidylcholine, egg phosphatidylethanolamine, sphingomyelin, dipalmitoyl-L-a-phosphatidic acid, and cholesterol (or alternatively 5-cholesten-3-one) were mixed from stock solutions in CHC13-CH30H (2:1 [vol/vol]) in the molar ratio 1:1:1:0.2:1.5 (47) . In some experiments, PA was omitted without any detectable effects on virus binding or fusion. To a mixture of 2,000 nmol of lipids, 18 mg of octylglucoside (1-O-n-octyl-f-D-glucopyranoside; Boehringer) was added, and the mixture was dried under a stream of nitrogen. Dried lipid films were dissolved in 2 ml of Ca2' and Mg2e-free phosphate-buffered saline (PBS), and the detergent was removed by dialysis against PBS. Liposomes were pelleted by centrifugation in a JA21 rotor (21,000 rpm) for 1 h at 4°C (Sorvall), and, finally, the pellets were resuspended in HNE buffer containing 5 mM HEPES, 150 mM NaCl, and 0.1 mM EDTA (pH 7.4).
For the preparation of LUV by freeze-thaw extrusion, lipids were mixed as described above. Dried lipids (20 ,umol each) were hydrated in 2 ml of HNE buffer and subjected to 5 to 10 cycles of freezing in liquid nitrogen and thawing in a water bath at 37°C. Extrusion was done five times through two stacked 0.2-,m-pore-size polycarbonate filters (Nuclepore Corp., Pleasanton, Calif.) with a pressure extruder (Lipex Biomembranes Inc., Vancouver, British Columbia, Canada).
Liposomes were stored under nitrogen at 4°C and used within 4 days of preparation. The phospholipid phosphate content was determined according to the method described by Botcher et al. (5) . In some experiments, liposomes lacking dipalmitoyl-L-a-phosphatidic acid were used. These vesicles were prepared as described above.
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Binding assay. To assess the interaction of the radioactively labeled virus with the liposomes, we used a coflotation assay involving sucrose gradients, essentially as described previously (21) . This assay measures both binding per se and fusion. Briefly, 0.2 to 5 mM LUV in 50 ,ul of HNE buffer was mixed with 0.5 to 1.5 ,ug of virus particles, and the mixture was incubated for 10 min at 37°C. Acidification was done by adding a pretitrated volume of 0.3 M MES [2-(N-morpholino)ethanesulfonic acid] buffer (pH 5.2) to obtain the final pH of 5.7 or 5.55, which was followed by an incubation at 37°C with continuous mixing. Samples were neutralized by the addition of a pretitrated volume of 0.1 N NaOH. The samples (30 ,ul each) were mixed with 1 ml of 46% (wt/vol) sucrose in 50 mM Tris-HCl-100 mM NaCl (pH 8.5; TN) in an SW50.1 tube, to yield a final sucrose concentration of 44%. Sucrose solutions (2.45 ml of 25% [wt/vol] sucrose and 1.45 ml of 5% [wt/vol] sucrose in TN) were layered on top to yield discontinuous gradients. After centrifugation in an SW50.1 rotor at 40,000 rpm for 2 h at 4°C, gradients were fractionated from the top and radioactivity in the fractions was measured by liquid scintillation counting. The radioactivity found in the top half of the gradient (fraction numbers 6 to 10) was defined as the cofloating virus material, that is, the virus bound to the vesicles. In some liposome preparations,
lipids) was included. This allowed the localization of the vesicles in the gradient. About 85% of the vesicles was found in the floating fractions, irrespective of treatment. The virus-liposome material in the sucrose-containing fractions was solubilized in 1% Nonidet P-40 (NP40; octylphenylpolyethylene glycol; Fluka) and used for several kinds of analyses of the viral proteins. The analyses included immunoprecipitation, sedimentation in sucrose density gradients, and SDS-polyacrylamide gel electrophoresis (PAGE).
Fusion assay. Fusion of virus and liposome membranes was assayed by lipid mixing with the pyrene-labeled virus preparations described above. Pyrene lipids in the membranes of virus particles have a characteristic fluorescence emission spectrum, with intense monomer peaks (M) at 378 and 398 nm and a broader excited dimer (excimer) peak (E) at 475 nm (12, 30) . Upon fusion with liposomes, the fluorescent probes in the virus membrane are diluted, resulting in a decrease in excimer fluorescence intensity and an increase in monomer intensity. We recorded the spectrum of the emitted fluorescence from 350 to 510 nm, slit 4 nm, during excitation at 343 nm, slit 2 nm, using an SLM 8000 fluorometer (SLM-Aminco, Urbana, Ill.). The samples were kept in quartz cuvettes, which were maintained at 37°C, with continuous stirring.
The ElM ratios, as calculated from the spectra at 480 and 398 nm, with peak heights as a measure of fluorescence intensity, were 0.24 for the wt and 0.22 for the mL virus. To quantitate the extent of fusion, the decrease in excimer fluorescence was continuously recorded from the addition of labeled virus to liposomes (0.5 ,uM viral phospholipid; 0. For time course analyses of conformational changes,
[35S]methionine-labeled virus was mixed with liposomes in the cuvette, and the mixture was incubated for 2, 5, 15, and 60 s at pH 5.55 and at 37°C. Samples were then neutralized and either (i) solubilized and used for immunoprecipitation analyses with the anti-El" antibody or (ii) solubilized and analyzed for the presence of El homotrimers by SDS-PAGE as described below. From studies with incubation mixtures at a pH value closer to the threshold for fusion or at a lower temperature, it is clear that the neutralization of the sample is sufficient to prevent any further conversions (6) .
Other methods. Immunoprecipitation analyses with the monoclonal antibodies anti-El", anti-El, anti-El', and anti-E2 were performed as described previously (46) . Sucrose density gradient analyses were done as described previously (46) . SDS-polyacrylamide gel analysis of El trimers was done following incubation of solubilized samples at 37°C for 2 min in SDS-PAGE sample buffer without dithiothreitol (45) . Proteins were resolved either on SDS-PAGE gels (10% polyacrylamide) with 5% stacking gels or on 5 to 12% polyacrylamide gradient gels with 5% stacking gels (7 
RESULTS
The El subunits form an NP40-resistant homotrimer during virus entry. In a previous study (46) , we have demonstrated that after virus entry into BHK cells, under the acidic conditions of the endosomes, the E2E1 heterodimeric spike protein of SFV dissociates and an NP40-resistant El oligomer is formed. To obtain insight into the size of this El oligomer, we analyzed virus and cell samples which had been treated with nonreducing SDS sample buffer at 37°C instead of at the normal temperature of 70°C in SDS-PAGE. A similar treatment has previously been shown to preserve the quaternary structure of the influenza virus spike protein (9) . We used [35Slmethionine-labeled SFV that was bound to cells at 0°C and then incubated for 10 min at 37°C to allow endocytosis of the virus. Virus-cell samples were solubilized with NP40 and used for sedimentation analysis in sucrose gradients (Fig. la) . In this analysis, the viral spike proteins E2 and El were separated into three major peaks, labeled I to III. In Fig. lb , the peak fractions have been subjected to SDS-PAGE with or without preheating at 70°C in SDS sample buffer. Consistent with earlier results, following treatment with SDS sample buffer at 70°C, the heaviest peak (III) contained only El and the lightest peak (I) contained only E2 subunits (Fig. lb, lanes 2 and 6, respectively ing band (Fig. lb, lane 1) . Further determination of the size of the slowly migrating band in a 5 to 12% acrylamide gradient gel with a set of marker proteins gave an apparent molecular mass of about 150 kDa (Fig. lc) , a size that closely corresponds to a trimer of the monomeric El subunit (molecular mass, 50 kDa). The material in peak II contained trace amounts of the 150-kDa El oligomer, probably due to peak contamination. The majority of the El protein present in this peak migrated as monomeric El, irrespective of whether it was incubated at 37°C with SDS sample buffer or heated to 70°C (Fig. lb, lanes 3 and 4) . All E2 proteins migrated as monomers (Fig. lb, lanes 3 to 6) . Parallel to the low-pH-induced formation of a homotrimeric structure, the El protein also exposes a unique epitope, recognized by a monoclonal antibody, anti-El' (45); in addition, the protein becomes trypsin resistant (18, 46) .
Virus binding to and fusion with liposomes. In order to be able to correlate the pH-dependent structural alterations in the El spike glycoprotein with the membrane fusion capacity of SFV, we studied the membrane interactions of the virus in in vitro model systems with large unilamellar lipid vesicles (liposomes) as target membranes. Two assays were used, one to determine the binding (including fusion) of the virus to the liposomes and the other to determine the actual merging of the viral and liposomal membranes. In the binding assay, described previously by Kielian and Helenius (21) , the association of the virus with the lipid vesicles is measured by coflotation of virus and liposomes in sucrose density gradients. Our experiments confirmed earlier findings that SFV associates with liposomes in vitro in a pHdependent manner (Fig. 2a and b) . Quantitation of the flotation results showed that 71% of the viral proteins cofloated with the liposomes after a treatment at pH 5.55, while at neutral pH the association was negligible ( Table 1) .
The fusion assay that was used relies on the measurement of lipid mixing between the viral and liposomal membranes. SFV was labeled biosynthetically with pyrene-labeled fatty acid, as described previously by Pal et (12) ; their formation is dependent on the distance between the probe molecules. Therefore, the pyrene excimer-to-monomer fluorescence ratio is proportional to the concentration of the pyrene probe. During the biosynthetic, labeling of SFV (30), the extent of probe incorporation in the virus membrane phospholipids corresponds to a surface density of the probe producing a significant excimer fluorescence intensity (Fig. 3a) . Consequently, during fusion between SFV labeled in this manner and liposomal target membranes the dilution of the pyrene phospholipids into the target membranes can be monitored as a decrease of the pyrene excimer fluorescence level. Figure 3b shows the pyrene fluorescence emission spectrum of SFV after incubation with liposomes during 10 min at pH 5.55 and at 37°C. Clearly, the low-pH incubation of the virus with liposomes, in contrast to a low-pH incubation of the virus alone (see Fig. 4a cholesterol analog 5-cholesten-3-one did not result in significant binding of the virus to or fusion with the liposomes (Fig. 2c ; data summarized in Table 1 ). Furthermore, both binding and fusion capacity were largely inactivated by a low-pH treatment of the virus alone prior to incubation with the liposomes (Fig. 2d and Table 1 ). Interaction of an SFV mutant (mL) with liposomes. To establish to what degree the in vitro binding and fusion assays reflect the physiological association and fusion events that take place between the virus particles and the membranes of a host cell, we analyzed the behavior of an SFV variant, the mL virus, in these assays. This SFV variant has two point mutations in the cleavage site of the p62 gene, resulting in the expression of uncleaved p62 protein and in the generation of noninfectious virus particles, which have p62El hetero-oligomers in their membranes instead of mature E2E1 oligomers. The p62E1 spikes are incapable of mediating efficient binding to cell membranes and of accomplishing fusion at pH conditions characteristic of SFV (34) . Under these conditions, the El subunit in the p62E1 spike is also incapable of forming homotrimers and of exposing anti-El' epitopes. However, the mL virus can be activated to carry out normal entry functions by artificial cleavage of the precursor with mild trypsin treatment in vitro. When used in the binding assay described above, the inactivated, uncleaved mL virus was unable to bind to liposomes, after incubation at pH 5.5 ( Fig. 2e and 4b) . In contrast, after trypsin activation the mL virus cofloated with the liposomes and 60% had fused with the latter ( Fig. 2f and 4b ; Table 1 ). binding and fusion of SFV with liposomes follow the same spike cleavage-regulated and low-pH-induced membrane fusion mechanism that is used during natural virus entry into a host cell. Thus, we conclude that the in vitro fusion reaction is very similar to the natural penetration process in an animal cell.
The results with the mL virus demonstrated that in vitro
Structural alterations in the El subunit during SFV fusion. To monitor the structural changes in the El subunit during SFV binding to and fusion with liposomes, we performed a quantitative analysis of the formation of El trimers and the exposure of the anti-El" epitope in virus-liposome mixtures, after a low-pH incubation and subsequent neutralization. The results showed that 72% of the El subunits exposed the anti-El" (Fig. 5a [upper panel] and Table 2 ) and 68% sedimented as homotrimers in sucrose density gradients (Fig. 5a [lower panel] and Table 2 ). The extent of El conversion reflected by these results was very similar to that observed after SFV entry into cells ( Table 2 ), indicating that the structural alterations that occur during entry of SFV into cells also appear during the in vitro fusion process.
It is important to note that the structural alterations in the Figure Sb and Table 2 show that efficient conversion of El into anti-El' epitope-carrying homotrimers takes place when the virus is mixed with 5-cholesten-3-one-containing liposomes. A total of 68% of the El appeared as NP40-resistant trimers, and 62% carried the anti-El" epitope. In this respect, it is noteworthy that we found the extent of El conversion (based on homotrimer formation and anti-El" epitope expression) after SFV entry into mosquito (Aedes albopictus) cells to be essentially independent of whether the cells were cholesterol depleted (results not shown). Table 2 also gives the El conversion efficiency when SFV had been incubated for 10 min at pH 5.55 and at 37°C, in the absence of supplementing liposomes. In this case, 61% of the El subunits exposed the anti-El" epitope while 58% migrated as 150-kDa El homotrimers during SDS-PAGE. However, if the incubation of virus with low pH was done at 4°C, virtually no conversion took place (data not shown), consistent with previous results (46) . From these results, we conclude that at 37°C, low pH is sufficient for triggering the formation of NP40-resistant El trimers in SFV virions.
The results described above show that the El trimerization and the expression of the anti-El" epitope, as they occur both during infectious-virus entry into cells and during in vitro fusion of SFV with liposomes, do not require cholesterol. At the same time, low-pH-induced virus binding and fusion are strictly dependent on the presence of cholesterol in the target membrane. In addition, El trimerization and the expression of the anti-El" epitope occur during a low-pH incubation of the virus alone, a condition resulting in a rapid inactivation of virus fusion capacity. Altogether, these observations raise the question of whether low-pH-induced structural alterations in the El protein are required for the expression of the membrane fusion activity of the virus. In the following sections, we present three lines of evidence indicating that the structural alterations in El are indeed critically involved in the activation of the membrane fusion capacity of SFV.
El conversion is involved in SFV binding to and fusion with liposomes. Quantitative analysis of the amount of structurally altered El, cofloating with cholesterol-containing liposomes on a sucrose density gradient after a low-pH treatment, revealed an enrichment of El homotrimers in the cofloating fractions. Of the total amount of 68% El trimers formed, 90% was found to float with the liposomes (data not shown). Likewise, virtually the total amount (92%) of El expressing the anti-El' epitope was present in the cofloating fractions. These results indicate that in the virus-liposome mixture, the virions that carry El homotrimers and express the anti-El' epitope are associated or fused with the liposomes.
In the experiment in which liposomes containing 5-cholesten-3-one rather than cholesterol were used, only a small fraction of the virus cofloated with the liposomes (Table 1) . However, all of the El proteins in this material were converted to El trimers and carried the anti-El" epitope (data not shown). From these results, we conclude that the formation of El trimers and the expression of the anti-El" epitope are involved in SFV binding to and fusion with cholesterol-containing liposomes.
The results shown in Fig. 6 demonstrated further that the low-pH-induced binding to and fusion with liposomes in vitro could be inhibited efficiently with the anti-El" monoclonal antibody. The presence of this antibody (7 to 15 ,ug/ml) in the virus-liposome mixture during the low-pH treatment reduced virus coflotation with liposomes from 83% without antibody to 9% with antibody and also reduced the fusion efficiency extensively. Addition of antibody after acidification had no effect on binding or fusion capacities (data not shown). No Fig. 7 . Clearly, at the earliest time point measured (2 s), the extent of El conversion had already reached its maximal value of 60 to 65%, as evident from both trimer formation and epitope expression. For reasons of comparison, we show the fusion kinetics at a liposome concentration similar to that used in the El conversion studies. Like the El conversion, fusion under these conditions also appeared virtually complete in a few seconds. The kinetic correlation between the conversion of El and the fusion of SFV with liposomes provides strong support for the idea that acidinduced El trimerization and expression of the anti-El" epitope are required for the activation of the fusion capacity of the virus.
DISCUSSION
The original SFV spike is characterized by the association of three E2E1 protomeric units. After solubilization with mild detergents like NP40, the E2E1 heterodimers can be easily identified by sedimentation analysis in sucrose gradients and by immunological analyses (35, 45, 49) . When the virus particle becomes exposed to low pH during endocytosis, several changes take place in the tertiary and quaternary structures of the spike proteins (18, 46) . These can be summarized as follows. The interactions between the subunits in the original E2El protomers are weakened and can no longer be detected after solubilization with NP40. Instead, a new NP40-resistant structure, consisting of El only, is formed. In this study, we have demonstrated that this structure is an El trimer. Parallel with forming a homotrimeric structure, El at low pH also exposes a specific epitope, recognized by the monoclonal antibody nti-El", which does not react with the original, neutral spike structure. Furthermore, the trimeric El is considerably more resistant toward trypsin than the El of the E2El heterodimer (18, 46) . This acid-induced El homotrimer might result from a low-pH-induced stabilization of substructures present in the original virus spike. Cross-linking studies by Anthony and Brown suggested that the El subunits are in close contact in the virus spike (2) . If one assumes that low pH dissociates the E2El interaction and concomitantly enforces the interactions between El subunits in the original spike structure, then the result would be the formation of an El homotrimer.
In the present study, we have shown that the same structural alterations in the El protein that occur during intracellular fusion of SFV from acidic endosomes also occur during in vitro fusion of the virus with liposomes. This in vitro fusion process exhibits the characteristics of the infectious fusion reaction of the virus with cells, in that it is strictly dependent on a mildly acidic pH and on the presence of cholesterol in the target membrane; also, the variant mL virus, which is not infectious unless pretreated with trypsin cleaving the p62 precursor of E2, does not fuse in vitro with liposomes without prior cleavage of p62. The fluorescence lipid-mixing assay used in the in vitro fusion studies permitted a kinetic assessment of the process. Thus, a temporal J. VIROL. correlation between the structural alterations in El, on the one hand, and fusion, on the other, could be established, strongly supporting the idea that the acid-induced homotrimeric form of El is the fusion-active structure of the protein. This idea is further supported by the fact that the anti-El" monoclonal antibody, which recognizes the El homotrimer, inhibits the in vitro binding and fusion processes.
The findings that the El homotrimeric structure is formed and that the anti-El" epitope is exposed upon low-pH treatment of the virus in the absence of target (6) . The viral spike proteins that are physically associated with the liposomal membrane may be influenced in the further course of the conformational change to produce a fusion-active El homotrimer, as opposed to a fusion-inactive trimer that would be produced during exposure of the isolated virus to low pH. In this respect, it is interesting to note that the rapid binding of the virus to liposomes does require cholesterol in the target membrane, implying that it cannot be excluded that cholesterol, although unnecessary for the El trimerization as such, may play a role in the formation of a fusionactive El homotrimer after all.
In contrast to the situation with SFV, there exists in the case of influenza virus good experimental evidence for the formation of low-pH-induced intermediate spike structures that are fusion active. Recent studies with influenza virus have demonstrated that upon acidification, the spike HA homotrimer initially changes its conformation into a form which exposes the N-terminal hydrophobic peptide of the HA2 subunit, the fusion peptide (for a review, see reference 39). This peptide inserts into the target membrane without any additional major conformational changes occurring in the protein molecule, resulting in membrane fusion. Following fusion, some further low-pH-independent changes take place, including the dissociation of the top domains of the HA trimers, resulting in inactivation of the fusion protein.
However, results from another recent study have suggested that some conformational changes in the top domains are still required for fusion, since introduction of intersubunit disulfide bonds in the globular top domains of HAl prevented the HA-induced cell-cell fusion capacity (14) . De- tailed analysis of the activation of the fusion capacity of the influenza virus HA (41) was made possible by the application of a kinetic fusion assay allowing the direct monitoring of the dilution of fluorescent probes from liposomal target membranes into the viral membrane (42) and through the availability of a large panel of conformation-specific monoclonal antibodies. The fusion assay used in the influenza virus studies is not readily applicable in the case of SFV fusion with liposomes, since this latter process in the absence of specific receptors for the virus of the liposomal membrane requires a large excess of liposomes. However, the fluorescence lipid-mixing assay presented in this study, in which the reporter probe molecules are present in the viral membrane, permits a similar, detailed kinetic assessment of the SFV fusion process. For the case of SFV, it will be most useful to combine such an analysis of fusion kinetics with the application of a panel of conformation-specific antibodies under conditions which support slow SFV fusion in vitro (higher pH values and lower temperatures). Several different conformation-specific antibodies have previously been described in studies with SFV (10, 20) . A detailed mapping of the SFV spike structure during virus fusion might reveal similarities or possible differences in the way in which alphavirus and orthomyxovirus fusion proteins activate membrane fusion.
